Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
$826.43
$1.72(0.29%)
At close: 4:00 PM EST
$826.43
$1.72(0.29%)
Day’s Range― - ―
52-Week Range$565.75 - $895.58
Previous CloseN/A
Volume137.88K
Average Volume (3M)800.64K
Market Cap
$102.00B
Enterprise Value$102.95B
Total Cash (Recent Filing)$4.11B
Total Debt (Recent Filing)$9.79B
Price to Earnings (P/E)25.7
Beta0.28
Next Earnings
Feb 04, 2026EPS Estimate
9.16Next Dividend Ex-DateN/A
Dividend Yield0.37%
Share Statistics
EPS (TTM)9.86
Shares Outstanding123,426,650
10 Day Avg. Volume796,895
30 Day Avg. Volume800,645
Financial Highlights & Ratios
PEG Ratio1.77
Price to Book (P/B)-41.34
Price to Sales (P/S)0.24
P/FCF Ratio16.41
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit7.94
Enterprise Value/Ebitda17.50
Forecast
1Y Price Target
$942.18Price Target Upside14.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
EPS Forecast (FY)38.94
Revenue Forecast (FY)$408.20B
Bulls Say, Bears Say
Bulls Say
Earnings GuidanceMCK raised its long-term adjusted EPS guidance, showing improved financial expectations.
Oncology And Multispecialty GrowthInvestments in oncology, multispecialty, and biopharma are expected to have higher margins and offer a long runway for growth.
Segment PerformanceMcKesson Corporation reported strong quarterly results, driven by impressive performance in North America Pharma and Oncology & Multispecialty segments.
Bears Say
Earnings MissMed Surg AOI of $249M missed cons of $255M.
Med Surg Segment ChallengesThe potential spin-off of MedSurg faces challenges due to competition and industry trends, which are seen as somewhat challenging.
Valuation ConcernsMedSurg peers trade at a discount to MCK’s current valuation, which is the biggest headwind to further multiple expansion for MCK.
McKesson News
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $565.75 and its highest was $895.58 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $102.00B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Feb 04, 2026 which is in 39 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Nov 05, 2025. The company reported $9.86 earnings per share for the quarter, beating the consensus estimate of $9.03 by $0.83.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.82 which represents an annual dividend yield of 0.37%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 9.16.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 123,426,650 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $9.86 in its last earnings report, beating expectations of $9.03. Following the earnings report the stock price went up 1.7%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
McKesson Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$942.18 (14.01% Upside)
$942.18 (14.01% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 85%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 9.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.77%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
16.20%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
MCK Company Deck
MCK Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
McKesson reported strong financial performance with significant growth in revenue and earnings, driven by robust performance in oncology and multispecialty segments and prescription technology solutions. The company raised its earnings guidance, reflecting confidence in continued growth. However, challenges in the Medical-Surgical Solutions segment present some concerns. Overall, the strengths significantly outweigh the challenges.View all MCK earnings summariesMCK Revenue Breakdown
91.27% U.S. Pharmaceutical
1.45% Prescription Technology Solutions
3.17% Medical-Surgical Solutions
4.10% International
<0.01% Corporate
MCK Stock 12 Month Forecast
Average Price Target
$942.18
▲(14.01% Upside)
Technical Analysis
Cencora
―
Cardinal Health
―
Henry Schein
―
Owens & Minor
―
Prestige Consumer Healthcare
―
Ownership Overview
0.03% Insiders
23.59% Mutual Funds
14.95% Other Institutional Investors
39.63% Public Companies and Individual Investors